Drug Type Gene editing |
Synonyms |
Target |
Mechanism STMN2 modulators(stathmin 2 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Arbor Biotechnologies, Inc.Startup |
Active Organization Arbor Biotechnologies, Inc.Startup |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Central Nervous System Diseases | Discovery | US | Arbor Biotechnologies, Inc.Startup | 06 Jul 2023 |